908 Devices director sells 40,000 shares in plan
908 Devices Inc. director Christopher D. Brown reported open-market sales of 40,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
908 Devices Inc. director Christopher D. Brown reported open-market sales of 40,000 shares of Common Stock. The transactions occurred over three days at prices around $7 per share, under a Rule 10b5-1 trading plan adopted on November 24, 2025.
Brown sold 15,030 shares at a weighted average price of $7.05 on April 8, 7,392 shares at $7.04 on April 9, and 17,578 shares at $7.07 on April 10. After these sales, he continues to hold 945,559 shares directly, indicating he retains a substantial equity position in the company.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 17,578 | $7.07 | $124K |
| Sale | Common Stock | 7,392 | $7.04 | $52K |
| Sale | Common Stock | 15,030 | $7.05 | $106K |
Footnotes (4)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.10 inclusive.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.14 inclusive.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
weighted average price financial
open-market sale financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did 908 Devices (MASS) director Christopher D. Brown report in this Form 4?
Were the 908 Devices (MASS) insider sales made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.